Cargando…

A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L

BACKGROUND: The COVID-19 pandemic has resulted in negative impacts on the economy, population health, and health-related quality-of-life (HRQoL). OBJECTIVE: To assess the impact of COVID-19 on US population HRQoL using the EQ-5D-5L. DESIGN: We surveyed respondents on physical and mental health, demo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hay, Joel W., Gong, Cynthia L., Jiao, Xiayu, Zawadzki, Nadine K., Zawadzki, Roy S., Pickard, A. Simon, Xie, Feng, Crawford, Samuel A., Gu, Ning Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939446/ https://www.ncbi.nlm.nih.gov/pubmed/33686587 http://dx.doi.org/10.1007/s11606-021-06674-z

Ejemplares similares

Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
por: Nazari, Jonathan L., et al.
Publicado: (2022)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
por: Jiang, Ruixuan, et al.
Publicado: (2020)

Where Do We Go From Here? A Framework for Using Susceptible-Infectious-Recovered Models for Policy Making in Emerging Infectious Diseases
por: Zawadzki, Roy S., et al.
Publicado: (2021)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions: Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling"
por: Zawadzki, Nadine K., et al.
Publicado: (2019)

Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
por: Janssen, M. F., et al.
Publicado: (2012)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2007)

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
por: Pickard, A Simon, et al.
Publicado: (2010)

P63 Impact of COVID-19 on Health-Related Quality-of-Life in the United States, Sweden and Norway: A Cross-Country Comparison Using a Panel Survey
por: Chen, J, et al.
Publicado: (2022)

General population normative data for the EQ-5D-3L in the five largest European economies
por: Janssen, Mathieu F., et al.
Publicado: (2021)

Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off
por: Jiang, Ruixuan, et al.
Publicado: (2020)

Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values
por: Krabbe, Paul F. M., et al.
Publicado: (2014)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
por: Martí-Pastor, Marc, et al.
Publicado: (2018)

Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers
por: Grazette, Luanda, et al.
Publicado: (2022)

Predicting panel attrition in longitudinal HRQoL surveys during the COVID-19 pandemic in the US
por: Yu, Tianzhou, et al.
Publicado: (2022)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset
por: Feng, You-Shan, et al.
Publicado: (2021)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

QALYs for COVID-19: A Comparison of US EQ-5D-5L Value Sets
por: Poteet, Stephen, et al.
Publicado: (2021)

Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population
por: Sun, Xiaowu, et al.
Publicado: (2023)

EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories
por: Kreimeier, Simone, et al.
Publicado: (2019)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

Agreement Among Paper and Electronic Modes of the EQ-5D-5L
por: Lundy, J. Jason, et al.
Publicado: (2020)

COVID-19 QALY values differ between US EQ-5D-5L value sets
Publicado: (2021)

Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults
por: Regan, Annette K., et al.
Publicado: (2023)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

The Indonesian EQ-5D-5L Value Set
por: Purba, Fredrick Dermawan, et al.
Publicado: (2017)

A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy
por: Wijnen, Ben F. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1im3r5p58lvqh7mcvha28u74jd